spike
protein
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
respons
receptor
bind
also
major
antigen
determin
capabl
induc
protect
immun
studi
demonstr
receptorbind
domain
rbd
protein
import
immunogen
site
patient
sar
rabbit
immun
inactiv
sarscov
serum
sampl
convalesc
sar
patient
immun
rabbit
potent
neutral
activ
infect
pseudoviru
express
sarscov
protein
deplet
rbdspecif
antibodi
patient
rabbit
immun
sera
immunoadsorpt
significantli
reduc
serummedi
neutral
activ
affinitypurifi
antirbd
antibodi
rel
higher
potenc
neutral
infect
sar
pseudoviru
indic
rbd
protein
critic
neutral
determin
sarscov
viral
infect
immun
two
monoclon
antibodi
target
rbd
protein
isol
mice
immun
inactiv
sarscov
possess
potent
neutral
activ
although
direct
distinct
conformationdepend
epitop
shown
elisa
bind
competit
assay
demonstr
abl
block
bind
rbd
angiotensinconvert
enzym
function
receptor
target
cell
data
provid
import
inform
understand
antigen
immunogen
sarscov
design
sar
vaccin
identif
critic
neutral
determin
sever
acut
respiratori
syndrom
sar
associ
coronaviru
import
design
sar
vaccin
global
emerg
sever
acut
respiratori
syndrom
sar
caus
new
coronaviru
sarscov
ksiazek
et
al
marra
et
al
peiri
et
al
rota
et
al
similar
coronavirus
sarscov
featur
larg
positivestrand
rna
genom
harbor
openread
frame
orf
encod
larg
polyprotein
requir
viru
replic
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
eight
addit
polypeptid
unknown
function
marra
et
al
rota
et
al
sarscov
infect
trigger
humor
cellular
immun
respons
viral
protein
human
high
rate
recoveri
acut
ill
sar
absenc
effect
medic
therapi
low
rate
reinfect
sarscov
suggest
protect
immun
achiev
recent
studi
demonstr
sera
convalescentphas
sar
patient
contain
high
titer
neutral
antibodi
sarscov
simmon
et
al
protein
sarscov
like
coronavirus
shown
major
antigen
determin
induc
neutral
antibodi
protect
immun
bisht
et
al
buchholz
et
al
bukreyev
et
al
yang
et
al
dna
vaccin
encod
protein
induc
sarscov
neutral
protect
immun
mice
deplet
cell
antibodi
transfer
experi
reveal
protect
mediat
neutral
antibodi
yang
et
al
protect
achiev
sole
administr
neutral
monoclon
antibodi
specif
protein
traggiai
et
al
furthermor
vaccin
anim
recombin
virus
attenu
vaccinia
viru
mva
parainfluenza
viru
express
protein
elicit
neutral
antibodi
protect
anim
sarscov
challeng
bisht
et
al
buchholz
et
al
bukreyev
et
al
infect
pseudoviru
express
sarscov
protein
effect
neutral
convalesc
sera
sar
patient
simmon
et
al
data
suggest
protein
sarscov
promis
candid
develop
sar
vaccin
protein
sarscov
larg
class
transmembran
glycoprotein
consist
domain
residu
domain
residu
mediat
attach
virion
suscept
cell
fusion
viral
cellular
membran
hofmann
pohlmann
holm
acid
small
fragment
residu
region
character
minim
receptorbind
domain
rbd
sarscov
babcock
et
al
wong
et
al
xiao
et
al
rbd
mediat
protein
bind
angiotensinconvert
enzym
function
receptor
sarscov
suscept
cell
dimitrov
li
et
al
prabakaran
et
al
recent
demonstr
recombin
rbd
sarscov
protein
could
induc
potent
neutral
antibodi
et
al
et
al
report
show
rbd
protein
critic
neutral
determin
sarscov
sar
patient
sarscovimmun
rabbit
identifi
two
neutral
epitop
rbd
monoclon
antibodi
mab
isol
mice
immun
inactiv
sarscov
demonstr
rbd
protein
highli
immunogen
mice
rabbit
immun
inactiv
sarscov
et
al
studi
serum
sampl
collect
sar
patient
convalesc
phase
investig
immunogen
rbd
human
sera
posit
sarscov
detect
elisa
commerci
avail
diagnost
kit
mixtur
protein
purifi
viral
lysat
sarscov
use
coat
antigen
data
shown
determin
antibodi
specif
rbd
protein
sar
convalesc
sera
use
recombin
coat
antigen
elisa
shown
fig
convalesc
sera
sar
patient
react
significantli
wherea
none
sera
healthi
blood
donor
reactiv
antigen
suggest
rbd
sarscov
protein
highli
immunogen
viru
infect
rbdfc
fusion
protein
use
isol
rbdspecif
antibodi
immunoaffin
chromatographi
convalesc
sera
sar
patient
serum
sampl
four
sar
patient
sar
ad
prescreen
high
level
reactiv
control
serum
health
blood
donor
adsorb
resin
immobil
rbdfc
fusion
protein
bound
antibodi
antirbd
elut
ph
buffer
effici
deplet
recoveri
rbdspecif
antibodi
monitor
measur
reactiv
start
human
sera
correspond
flowthrough
elut
antibodi
fraction
elisa
shown
fig
reactiv
antirbd
sera
sar
patient
effici
remov
rbdfc
affin
column
elut
antirbd
antibodi
could
significantli
react
sampl
correspond
start
sera
flowthrough
antirbd
deplet
eluat
antirbd
fig
measur
rbdspecif
antibodi
sera
convalescentphas
sar
patient
elisa
recombin
use
coat
plate
sera
sar
patient
healthi
blood
donor
test
dilut
sera
consid
posit
optic
densiti
valu
cutoff
valu
mean
absorb
nm
sera
healthi
blood
donor
plu
three
standard
deviat
antibodi
reactiv
elisa
fig
suggest
convalesc
sera
sar
patient
contain
abund
antibodi
specif
protein
rbdspecif
antibodi
specif
isol
immunoaffin
chromatographi
entri
sarscov
target
cell
initi
bind
protein
via
rbd
region
cellular
receptor
shown
fusion
protein
rbdfc
contain
rbd
protein
potent
induc
neutral
antibodi
sarscov
immun
anim
et
al
interest
know
whether
rbd
protein
mediat
antibodi
respons
respons
viru
neutral
infect
sar
patient
therefor
neutral
activ
sampl
start
sera
flowthrough
eluat
determin
use
sar
pseudoviru
strikingli
neutral
activ
patient
sera
significantli
reduc
deplet
antirbd
antibodi
antirbd
antibodi
eluat
possess
higher
potenc
antibodi
flowthrough
neutral
sar
pseudoviru
fig
tabl
suggest
neutral
activ
convalesc
sera
sar
patient
contribut
rbdspecif
antibodi
contrast
serum
sampl
includ
start
sera
flowthrough
eluat
healthi
blood
donor
neutral
activ
pseudoviru
data
shown
data
indic
rbd
protein
import
induc
neutral
antibodi
viral
infect
previous
demonstr
inactiv
sarscov
abl
induc
neutral
antibodi
immun
rabbit
et
al
elucid
neutral
determin
sarscov
rbdspecif
antibodi
isol
immunoaffin
chromatographi
four
rabbit
antisera
ad
similarli
reactiv
antirbd
antibodi
rabbit
antisera
could
effici
deplet
rbdfc
affin
column
sinc
flowthrough
bind
rbdfc
elut
antirbd
antibodi
significantli
react
rbdfc
fig
sampl
correspond
start
sera
flowthrough
antirbd
deplet
sera
eluat
contain
antirbd
antibodi
similar
reactiv
fig
neutral
activ
antirbd
antibodydeplet
rabbit
antisera
much
lower
start
sera
antirbd
antibodi
possess
potent
activ
neutral
sar
pseudoviru
fig
tabl
data
suggest
rbd
protein
effect
induc
neutral
antibodi
virusimmun
rabbit
shown
inactiv
sarscov
induc
high
titer
antibodi
specif
rbd
protein
immun
mice
et
al
identifi
neutral
epitop
sarscov
two
mab
target
rbd
protein
isol
mice
immun
inactiv
sarscov
epitop
specif
initi
determin
elisa
use
rbdfc
dttreduc
rbdfc
dttreduc
coat
antigen
fig
b
mab
reactiv
nativ
rbdfc
dttreduc
rbdfc
indic
direct
disulfid
bonddepend
conform
epitop
express
rbd
protein
two
mab
compet
elisabas
bind
competit
assay
fig
suggest
epitop
locat
differ
site
rbd
fig
isol
rbdspecif
antibodi
sera
convalescentphas
sar
patient
immunoaffin
chromatographi
serum
sampl
adsorb
rbdfc
column
bound
antibodi
elut
ph
patient
sera
flowthrough
eluat
test
respect
b
dilut
elisa
one
serum
sampl
healthi
blood
donor
use
control
rbdfc
could
effici
bind
express
cell
measur
flow
cytometri
test
whether
rbdspecif
mab
inhibit
bind
rbdfc
cellassoci
shown
fig
abl
block
rbdfc
bind
cell
result
suggest
recogn
epitop
may
overlap
receptorbind
site
protein
direct
distinct
conformationdepend
epitop
involv
receptor
bind
singlecycl
infect
assay
test
neutral
activ
two
mab
sar
pseudoviru
strikingli
potent
neutral
sar
pseudoviru
neutral
dose
nd
agml
agml
respect
fig
suggest
conformationdepend
epitop
rbd
protein
elicit
potent
neutral
antibodi
protein
sarscov
abl
induc
protect
immun
immun
anim
bisht
et
al
buchholz
et
al
bukreyev
et
al
yang
et
al
use
set
overlap
peptid
cover
entir
sequenc
protein
identifi
sever
immunodomin
domain
within
protein
howev
none
domain
model
linear
peptid
abl
elicit
neutral
antibodi
et
al
contrast
rbd
residu
region
protein
induc
highli
potent
neutral
antibodi
sarscov
et
al
et
al
demonstr
rbd
sarscov
protein
immunogen
site
induc
antibodi
respons
sarscovinfect
patient
immun
rabbit
immunoabsorpt
assay
demonstr
antirbd
antibodi
function
main
popul
neutral
antibodi
suggest
rbd
protein
import
neutral
determin
sarscov
first
essenti
step
coronaviru
infect
interact
protein
via
rbd
specif
cellular
receptor
rbd
protein
coronavirus
mous
hepat
viru
mhv
transmiss
gastroenter
viru
tgev
human
coronaviru
also
contain
major
antigen
determin
capabl
induc
neutral
antibodi
bonavia
et
al
godet
et
al
kubo
et
al
previous
demonstr
inactiv
sarscov
vaccin
capabl
induc
high
titer
rbdspecif
antibodi
block
receptor
bind
viru
entri
et
al
present
studi
two
neutral
epitop
rbd
protein
identifi
mab
isol
mice
immun
inactiv
sarscov
therefor
rbd
protein
may
serv
import
target
site
develop
sar
vaccin
immunotherapeut
inactiv
sarscov
use
one
major
vaccin
candid
current
test
clinic
trial
china
marshal
enserink
howev
caution
taken
use
inactiv
sarscov
vaccin
sinc
contain
number
viral
compon
may
induc
harm
immun
andor
inflammatori
respons
enserink
et
al
oba
wang
lu
fig
isol
character
rbdspecif
antibodi
rabbit
antisera
immunoaffin
chromatographi
reactiv
rabbit
antibodi
rbdfc
b
test
dilut
elisa
c
neutral
activ
rbdspecif
antibodi
isol
rabbit
antisera
inhibit
sar
pseudoviru
infect
cell
rabbit
antisera
flowthrough
eluat
respect
seri
dilut
determin
percent
neutral
calcul
sampl
cov
vaccin
trigger
autoimmun
respons
carbohydr
moieti
abund
human
serum
glycoprotein
asialoorosomucoid
recombin
virus
dna
vaccin
express
fulllength
protein
also
consid
sar
vaccin
candid
bisht
et
al
buchholz
et
al
bukreyev
et
al
yang
et
al
howev
fulllength
protein
also
contain
sever
linear
immunodomin
domain
induc
high
titer
nonneutr
antibodi
et
al
unclear
whether
nonneutr
antibodi
may
enhanc
sarscov
infect
mediat
harm
immun
respons
report
vaccin
ferret
vaccinia
virusbas
sar
vaccin
express
fulllength
protein
aggrav
liver
damag
caus
sarscov
infect
enserink
weingartl
et
al
demonstr
protein
felin
coronaviru
fipv
express
recombin
vaccinia
caus
antibodydepend
enhanc
diseas
vaccin
anim
subsequ
infect
wildtyp
viru
corapi
et
al
olsen
et
al
vennema
et
al
therefor
propos
use
rbd
sarscov
protein
develop
effect
safe
subunit
vaccin
sinc
rbd
protein
function
domain
mediat
virusreceptor
bind
also
critic
neutral
determin
sarscov
effect
rbdbase
sar
vaccin
develop
may
provid
promis
exampl
design
vaccin
virus
recombin
protein
sarscov
strain
express
previous
describ
et
al
et
al
plasmid
encod
acid
fragment
rbd
residu
link
fc
domain
human
design
rbdfc
tag
design
plasmid
encod
residu
correspond
domain
protein
tag
cterminu
design
kindli
provid
dr
farzan
harvard
medic
school
wong
et
al
rbdfc
protein
express
cell
transfect
plasmid
use
fugen
reagent
boehring
mannheim
indianapoli
accord
manufactur
protocol
supernat
harvest
h
posttransfect
purifi
affin
chromatographi
mab
nation
cell
cultur
center
minneapoli
mn
rbdfc
purifi
protein
sepharos
fast
flow
amersham
bioscienc
piscataway
nj
serum
sampl
collect
convalesc
sar
patient
day
onset
symptom
base
clinic
diagnosi
sar
epidem
beij
diagnost
criteria
sarscov
infect
follow
clinic
descript
sar
releas
sera
heatinactiv
prior
perform
experi
verifi
posit
sarscov
detect
immunofluoresc
assay
ifa
enzymelink
immunoabsorb
assay
elisa
use
commerci
avail
diagnost
kit
beij
genom
institut
beij
sera
collect
healthi
blood
donor
use
control
inactiv
sarscov
prepar
describ
previous
et
al
et
al
briefli
sarscov
strain
propag
cell
inactiv
hpropiolacton
inactiv
viru
purifi
desalt
sephadex
concentr
filtrat
sepharosecl
sequenti
purifi
viral
particl
puriti
hplc
analysi
four
nzw
rabbit
primarili
immun
intraderm
ag
purifi
inactiv
virus
immunogen
presenc
complet
freund
adjuv
fca
boost
twice
amount
freshli
prepar
emuls
immunogen
freund
incomplet
adjuv
fia
interv
preimmun
sera
collect
primari
immun
antisera
collect
day
second
boost
immunoaffin
resin
prepar
coupl
rbdfc
fusion
protein
cyanogen
bromideactiv
sepharos
bead
pharmacia
piscataway
nj
accord
manufactur
instruct
immunoadsorpt
human
rabbit
serum
sampl
dilut
pb
incub
rbdfc
resin
overnight
constant
rotat
resin
pack
column
flowthrough
antirbd
deplet
collect
wash
column
volum
pb
bound
antibodi
antirbd
elut
glycinehcl
buffer
ph
lowph
eluat
neutral
immedi
ph
tri
buffer
bovin
serum
albumin
agml
ad
stabil
buffer
exchang
pb
sever
cycl
dilut
concentr
amicon
centrifug
filter
devic
millipor
corpor
bedford
sampl
adjust
origin
volum
serum
steril
pore
size
microspin
filter
millipor
balbc
mice
immun
inactiv
sarscov
describ
previous
et
al
et
al
hybridoma
produc
mab
gener
use
standard
protocol
briefli
splenocyt
immun
mice
harvest
fuse
myeloma
cell
cell
cultur
supernat
well
contain
hybridoma
coloni
screen
ifa
cell
posit
well
expand
retest
cultur
remain
posit
subclon
gener
stabl
hybridoma
cell
line
mous
ascit
gener
inject
balbc
mice
hybridoma
mab
purifi
mous
ascit
protein
sepharos
fast
flow
amersham
bioscienc
isotyp
mab
determin
mous
monoabid
kit
zyme
south
san
francisco
ca
human
rabbit
serum
sampl
mous
mab
test
recombin
protein
rbdfc
elisa
respect
briefli
ag
ml
recombin
protein
coat
microtit
plate
corn
costar
acton
carbon
buffer
ph
overnight
block
nonfat
milk
dilut
sampl
ad
incub
h
follow
three
wash
pb
contain
tween
bound
antibodi
detect
hrpconjug
goat
antihuman
igg
goat
antirabbit
igg
goat
antimous
igg
zyme
south
san
francisco
ca
respect
h
follow
wash
reaction
visual
addit
substrat
tmb
absorb
nm
measur
elisa
plate
reader
tecan
us
research
triangl
park
nc
determin
effect
disulfid
bond
reduct
bind
rbdspecif
mab
elisa
plate
coat
recombin
rbdfc
concentr
agml
treat
h
dithiothreitol
dtt
concentr
mm
follow
wash
well
treat
mm
iodoacetamid
h
wash
standard
elisa
perform
describ
competit
elisa
perform
determin
inhibitori
activ
rbdspecif
mab
bind
biotinyl
mab
rbdfc
briefli
well
elisa
plate
coat
rbdfc
agml
describ
mixtur
agml
unlabel
mab
agml
biotinyl
mab
ad
follow
incub
h
bind
biotinyl
mab
detect
addit
hrpconjug
streptavidin
zyme
tmb
sequenti
biotinyl
mab
perform
use
ezlink
nhspeo
solid
phase
biotinyl
kit
pierc
rockford
il
accord
manufactur
protocol
inhibit
mab
rbdfc
bind
cell
measur
flow
cytometri
briefli
cell
detach
collect
wash
hank
balanc
salt
solut
hbss
sigma
st
loui
mo
rbdfc
ad
cell
final
concentr
agml
presenc
absenc
agml
mab
follow
incub
room
temperatur
min
cell
wash
hbss
incub
antihuman
iggfitc
conjug
zyme
dilut
room
temperatur
addit
min
wash
cell
fix
formaldehyd
pb
analyz
becton
facscalibur
flow
cytomet
mountain
view
ca
use
cellquest
softwar
sar
pseudoviru
prepar
previous
describ
et
al
et
al
brief
cell
cotransfect
plasmid
encod
codonoptim
protein
sarscov
strain
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
reagent
boehring
mannheim
supernat
contain
pseudoviru
bear
sarscov
protein
harvest
h
posttransfect
use
singlecycl
infect
cell
briefli
cell
plate
cellswel
tissuecultur
plate
grown
overnight
pseudoviru
preincub
serial
dilut
serum
sampl
mab
h
addit
cell
cultur
refe
fresh
medium
h
later
incub
addit
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
madison
wi
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
corn
ny
follow
addit
luciferas
substrat
promega
rel
light
unit
determin
immedi
ultra
luminomet
tecan
us
